Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia
EIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate...
Health News 2 me
healthnews2me.com
Tag: mild-to-moderate